Trulieve Cannabis Corp. (TRLV)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNYSEUnited StatesUS89790E1064
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Trulieve Cannabis Corp., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 17:01. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 0.12 | — | — | Upcoming |
| 05 Nov 2026 06:00 | 0.07 | 0.09 | +28.6% | Beat |
| 07 Aug 2026 06:00 | 0.03 | 0.11 | +266.7% | Beat |
| 07 May 2026 06:00 | -0.05 | 0.10 | +300.0% | Beat |
| 26 Feb 2026 06:00 | -0.03 | -0.02 | +31.0% | Beat |
| 05 Nov 2025 06:00 | -0.07 | -0.07 | -3.3% | Miss |
| 06 Aug 2025 06:00 | -0.05 | -0.04 | +24.2% | Beat |
| 07 May 2025 06:00 | -0.09 | -0.02 | +77.8% | Beat |
| 27 Feb 2025 06:00 | -0.35 | 0.02 | +105.7% | Beat |
| 05 Nov 2024 06:00 | -0.13 | -0.06 | +55.5% | Beat |
| 06 Aug 2024 07:00 | -0.09 | — | +100.0% | — |
| 09 May 2024 06:00 | -0.11 | -0.05 | +53.1% | Beat |
| 29 Feb 2024 06:00 | -0.13 | -0.12 | +8.4% | Beat |
| 09 Nov 2023 06:00 | -0.15 | -0.08 | +47.4% | Beat |
| 09 Aug 2023 07:00 | -0.18 | -0.08 | +56.5% | Beat |
| 10 May 2023 06:00 | -0.16 | -0.11 | +29.7% | Beat |
| 08 Mar 2023 06:00 | -0.08 | -0.18 | -121.5% | Miss |
| 09 Nov 2022 16:00 | -0.03 | 0.02 | +158.8% | Beat |
| 10 Aug 2022 06:00 | 0.08 | -0.01 | -112.4% | Miss |
| 12 May 2022 06:00 | 0.06 | 0.01 | -84.4% | Miss |
| 30 Mar 2022 10:00 | 0.16 | 0.01 | -93.7% | Miss |
| 15 Nov 2021 06:00 | 0.28 | 0.17 | -39.9% | Miss |
| 12 Aug 2021 07:00 | 0.30 | 0.33 | +9.1% | Beat |
| 13 May 2021 07:00 | 0.31 | 0.27 | -14.6% | Miss |
| 23 Mar 2021 11:00 | 0.24 | 0.33 | +40.0% | Beat |
| 17 Nov 2020 07:00 | 0.21 | 0.04 | -81.0% | Miss |
| 12 Aug 2020 07:00 | 0.12 | 0.06 | -49.3% | Miss |
| 20 May 2020 07:00 | 0.11 | 0.12 | +7.6% | Beat |
| 08 Apr 2020 07:00 | 0.11 | 0.34 | +207.1% | Beat |
| 18 Nov 2019 17:00 | 0.13 | 0.55 | +328.0% | Beat |
| 14 Aug 2019 17:00 | 0.12 | 0.52 | +347.0% | Beat |
| 28 May 2019 19:00 | 0.11 | 0.13 | +20.9% | Beat |
| 10 Apr 2019 19:00 | 0.07 | 0.10 | +49.3% | Beat |
| 19 Nov 2018 07:00 | 0.14 | 0.18 | +28.6% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.2B | -0.4% | -116.4M | -9.9% | -0.61 | +25.6% | 212.3M |
| 2024 | 1.2B | +5.1% | -155.1M | -13.1% | -0.82 | +70.6% | 123.8M |
| 2023 | 1.1B | -7.3% | -526.8M | -46.7% | -2.79 | -113.0% | 151M |
| 2022 | 1.2B | — | -246.1M | -20.2% | -1.31 | — | -170.7M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 10.38 | 12.05 | 10.35 | 10.71 | +4.18% | 14,748,117 | |
| Oct 2026 | 10.87 | 11.66 | 9.79 | 10.28 | -5.69% | 30,143,500 | |
| Sep 2026 | 11.54 | 12.93 | 10.22 | 10.90 | -5.30% | 56,096,800 | |
| Aug 2026 | 8.45 | 11.93 | 8.28 | 11.51 | +33.06% | 22,478,900 | |
| Jul 2026 | 9.85 | 10.10 | 7.82 | 8.65 | -12.00% | 19,661,100 | |
| Jun 2026 | 9.25 | 13.28 | 7.92 | 9.83 | +5.84% | 39,993,000 | |
| May 2026 | 9.85 | 10.08 | 7.17 | 9.29 | -5.61% | 7,807,900 | |
| Apr 2026 | 5.40 | 10.10 | 5.40 | 9.84 | +75.71% | 11,557,800 | |
| Mar 2026 | 6.39 | 7.14 | 5.00 | 5.60 | -12.36% | 4,553,500 | |
| Feb 2026 | 6.91 | 7.70 | 5.99 | 6.39 | -7.53% | 4,074,500 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Trulieve Announces November 2026 Event Participation (opens in a new tab) 11 Nov 2026 13:00
- Trulieve Expands Medical Cannabis Access through Riverside Pharmacy in Gainesville, Georgia (opens in a new tab) 10 Nov 2026 13:00
- Trulieve Cannabis Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 08 Nov 2026 17:14
- Trulieve Cannabis Corp. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 06 Nov 2026 02:01
- Trulieve (TRLV) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 20:45
- Trulieve Cannabis Corp. Reports Third Quarter 2026 Revenue of $230 million (opens in a new tab) Fintel · 05 Nov 2026 15:22
- Trulieve Cannabis Corp. (TRLV) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 05 Nov 2026 13:44
- Trulieve Reports Third Quarter 2026 Results (opens in a new tab) 05 Nov 2026 11:15
- Trulieve Cannabis Q3 Adj. EPS $0.09 Beats $0.05 Estimate, Sales $230.000M Beat $218.321M Estimate (opens in a new tab) Benzinga · 05 Nov 2026 07:16
- What Just Happened With Trulieve Cannabis (TRLV) Shares? (opens in a new tab) Simply Wall St. · 03 Nov 2026 03:16
- Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations (opens in a new tab) 02 Nov 2026 14:17
- Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target (opens in a new tab) Benzinga · 02 Nov 2026 13:49
- Trulieve Cannabis Awarded Registrations For Medical Marijuana Dispensaries From U.S. Drug Enforcement Administration (opens in a new tab) Benzinga · 02 Nov 2026 10:24
- Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis (opens in a new tab) Zacks · 12 Oct 2026 12:55
- 3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds (opens in a new tab) Zacks · 09 Oct 2026 13:31
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 11.15 USD
- Market cap
- 1.9B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow TRLV and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.